Medivir AB (publ) (STO:MVIR)

Medivir AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	193	319	159	552	624	201
Market Cap Growth	-49.19%	100.21%	-71.16%	-11.61%	209.74%	-33.10%
Enterprise Value	162	236	110	424	411	119
Last Close Price	1.72	2.84	2.85	8.11	9.18	5.58
PS Ratio	48.48	91.43	20.85	125.15	19.27	9.86
PB Ratio	2.43	2.76	0.73	2.86	2.22	1.42
P/TBV Ratio	2.43	2.76	0.73	2.86	2.22	1.42
EV/Sales Ratio	40.75	67.61	14.40	96.27	12.69	5.82
Debt / Equity Ratio	0.09	0.10	0.06	0.08	0.05	0.12
Asset Turnover	0.02	0.02	0.03	0.02	0.12	0.08
Quick Ratio	0.71	1.36	3.03	4.37	5.40	2.25
Current Ratio	0.71	1.38	3.05	4.39	5.42	2.28
Return on Equity (ROE)	-76.62%	-73.97%	-43.50%	-37.46%	-29.84%	-26.12%
Return on Assets (ROA)	-32.17%	-34.76%	-22.21%	-19.43%	-15.27%	-15.68%
Return on Capital (ROIC)	-45.48%	-44.71%	-26.36%	-22.00%	-17.75%	-19.66%
Earnings Yield	-50.69%	-38.71%	-56.14%	-16.09%	-10.11%	-21.15%
FCF Yield	-	-38.99%	-37.50%	-18.53%	-7.81%	-30.14%
Buyback Yield / Dilution	-28.57%	-88.71%	-8.44%	-5.53%	-117.45%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.